In May 2024, Nguyen Minh, Chairman of Vietnam CNC Veterinary Production and Trading Joint Stock Company (AniVacC Jsc.), and his delegation visited WIXBIO. They aimed to exchange in-depth information on the current trends of epidemic diseases, product R&D and innovation, technology transfer, exchange of talents, and critical technological research and development and lay a solid foundation for future strategic cooperation.
In-depth discussion on cooperation and development During the visit, Chairman Ruan Minh and the CNC team spoke with WIXBIO senior management several times. The two sides focused on the current disease prevention and control situation, especially the demand for preventing and controlling swine foot-and-mouth disease, avian influenza H5+H9, and duck Tambucus. They shared the latest progress of their respective vaccine R&D, technological innovation, and product transformation.WIXBIO introduced its strengths in vaccine R&D and production, especially its leading ability in customized vaccine production and technical support.
Chairman Nguyen Minh said CNC has always been committed to improving agriculture and animal disease prevention in Vietnam and neighboring areas. This visit gave CNC a better understanding of WIXBIO’s technical strength and R&D capability and opened up more possibilities for the two sides in technical cooperation and product promotion.
Signing a strategic cooperation agreement to promote technological breakthroughs jointly
Both parties reached a consensus during the discussion and plan to sign a comprehensive strategic cooperation agreement shortly to strengthen further the cooperation in vaccine R&D, technical support, and marketing. It is expected that by 2025, CNC will successfully obtain import registration certificates for nine animal vaccine products issued by the Ministry of Agriculture of Vietnam, covering vaccines for several significant epidemics, such as foot-and-mouth disease in pigs, avian influenza H5+H9, and duck Tambusu, with the technical and product support of WIXBIO.
The signing of this strategic cooperation agreement not only marks the further expansion of WIXBIO in the Southeast Asian market but also demonstrates the potential for in-depth cooperation between the two parties in animal vaccines. WIXBIO will provide CNC with a full range of product support and technical training in the future, which will help CNC enhance its competitiveness in the vaccine market in Vietnam and even the whole Southeast Asian region.
Mutual trust and win-win cooperation to promote the development of the industry Through innovation and cooperation.
WIXBIO has always been committed to providing customers with higher quality and more competitive animal vaccine products. The collaboration with CNC is an essential step for WIXBIO in the global vaccine industry chain. Both parties will continue to strengthen technical exchanges and cooperation in the future and jointly promote breakthroughs in animal vaccine research and development to contribute significantly to preventing global animal epidemics.
